WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 575256
Description: Itanoxone is a hypolipidemic and hypouricemic compound.
MedKoo Cat#: 575256
Chemical Formula: C17H13ClO3
Exact Mass: 300.0553
Molecular Weight: 300.74
Elemental Analysis: C, 67.90; H, 4.36; Cl, 11.79; O, 15.96
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: F 1379; F1379; F-1379; Itanoxone
IUPAC/Chemical Name: (1,1'-Biphenyl)-4-butanoic acid, 2'-chloro-alpha-methylene-gamma-oxo-
InChi Key: HJWLWNLAIBFKDO-UHFFFAOYSA-N
InChi Code: InChI=1S/C17H13ClO3/c1-11(17(20)21)10-16(19)13-8-6-12(7-9-13)14-4-2-3-5-15(14)18/h2-9H,1,10H2,(H,20,21)
SMILES Code: OC(=O)C(=C)CC(=O)c1ccc(cc1)c2ccccc2Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 300.74 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1. Livio M, Palmier C, Villa S, Maynadier B, Delhon A, Lauressergues H, de Gaetano G. Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in rats. Atherosclerosis. 1981 Jul;39(4):469-77. doi: 10.1016/0021-9150(81)90005-8. PMID: 7259827.
2. Crawley FE, Hyacinthe R, Poitou P, Donath A. Pharmacokinetics, metabolism and elimination of itanoxone in humans. Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):287-96. doi: 10.1007/BF03188759. PMID: 6653619.
3. Chanal JL, Audran M, Bret MC, Cousse H, Fauran F, Rieu JP. Comparison of the metabolism and pharmacokinetics of metbufen and itanoxone and their analogues in rats. Arzneimittelforschung. 1988 Oct;38(10):1454-60. PMID: 3196384.